🇺🇸 FDA
Pipeline program

Bioengineered Artificial Mesenchimal Sheet (BAMS)

UV/AP/21

Phase 2 mab active

Quick answer

Bioengineered Artificial Mesenchimal Sheet (BAMS) for Venous Ulcer is a Phase 2 program (mab) at Design Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Venous Ulcer
Phase
Phase 2
Modality
mab
Status
active

Clinical trials